Advertisement

Scientific Forums/Special Focus Groups

        Wednesday, February 9, 2005

        Tabled 1
        GroupRoomStart Time
        ComputersWhitney3:00pm
        Critical CareTeton3:00pm
        DiabetesSierra 13:00pm
        GeneticsMcKinley3:00pm
        HypertensionCarson 13:00pm
        Infectious DiseasesCascade3:00pm
        Maternal-Fetal SurgeryShasta3:00pm
        Perinatal EpidemiologyCrystal 53:00pm
        PrematurityCrystal 1-23:00pm
        UltrasoundCrystal 3-43:00pm

        Thursday, February 10, 2005

        Tabled 1
        Women In Perinatology11:30 am-1:00 pmSierra
        Special Focus Group Box Lunch
        Research Support Personnel11:30 am-1:00 pmTeton
        Special Focus Group Box Lunch Meeting
        International Society of Perinatal5:30 pm-7:30 pmSierra
        Obstetricians Scientific Forum

        Friday, February 11, 2005

        Tabled 1
        ISPO Breakfast Meeting7:00 am-8:00 amCrystal 1-2
        Other Special Focus Group Meetings:
        North American Society of Obstetric Medicine (NASOM) – Special Focus Group Meeting & Reception – February 8 – 6:00-8:00pm – Nevada 1
        Department of Defense (DoD) MFM Network – Special Focus Group Meeting – February 10 – 6:00-7:15am – Nevada 10
        Pro-Life MFMs – Special Focus Group Meeting – February 10 – 5:30-7:30pm – Nevada 8
        The Virtual MFM: A New Paradigm for High Risk Ob Care Across Networks – Special Focus Group Meeting – February 11 – 7:00-8:00am – Teton 1
        Nutrition Special Focus Group Meeting – TBA

        Scientific Forums

        Society for Maternal-Fetal Medicine 2005 Meeting Reno, NV

        Wednesday, February 9, 2005
        Computers in Maternal-Fetal Medicine3:00-6:00pm
        Leader: Andrzej J. Lysikiewicz, MD
        Co-leaders: J. Shumway, MD and W. Cusick, MD
        Tabled 1
        I. Welcome3:00
         Andrzej Lysikiewicz, MD
        II. Computerized labor management – Can a computer replace our fingers?3:00-3:20pm
         Dan Farine MD
         Mount Sinai Hospital
         Toronto, ONT
        III. Computerized Labor Monitoring3.20-3:40pm
         Yehuda Scharf, MSC
         R&D Barnev Ltd.
         Netanya, Israel
        IV. New developments in computer generated 4D Fetal Echocardiography3:40-4:00pm
         Dev Maulik, MD, PhD
         Winthrop Hospital
         New York, NY
        V. AI for First Trimester Genetic Mapping by Ultrasound4.00-4:20pm
         Shraga Rottem M.D., D.Sc
         Columbia University
         New York, NY
        VI. Computer assisted 3 D fetal biometry, VOCAL and other techniques4:20-4:40pm
         Andrzej Lysikiewicz, MD, PhD
         Winthrop Hospital
         New York, NY
        VII. Open Forum4:40-6:00pm
        Speakers interested in presenting during open forum please contact:
         A. Lysikiewicz MD
         Winthrop Hospital, Mineola, NY
         120 Mineola Blvd Suite 110
         N.Y, N.Y.11501
         Tel - 516 663 3020 [email protected]
        Critical Care in Obstetrics3:00-5:00pm
        Leader: Stephanie R. Martin, DO
        Tabled 1
        I. Introduction and Welcome to Participants
        II. Case presentation by Physician-in-Training followed by Discussion/presentations by Attending Physicians
         A. Managing Bleeding without Blood Products
          Walter Harry, MD
          Maternal Fetal Medicine Fellow
          University of Arizona, Tucson, AZ and
          Banner Good Samaritan Regional Medical Center
          Phoenix, AZ
          Stephanie R. Martin, DO
          Associate Director, Maternal Fetal Medicine
          Phoenix Perinatal Associates
         B. Not Your Typical Abdominal Pain
          Leah Battista, MD
          University of California Irvine Medical Center
          Orange, CA
          Deborah Wing, MD
          University of California Irvine Medical Center
          Orange, CA
         C. Hepatitis and Encephalitis – What's the Connection?
          Connie Graves, MD
          Vanderbilt University
          Nashville, TN
        Conclusion/Closing Remarks: Stephanie R. Martin, DO
        Diabetes3:00-5:00pm
        Leader: Siri L. Kjos, MD
        Tabled 1
        I. Greetings and Announcements
         Siri Kjos, MD
        II. Diabetes after GDM: What cause it and what can we3:00-4:00pm
         Do to prevent it?
          Thomas A. Buchanan, MD
          USC Keck School of Medicine
          Los Angeles, CA
        III. Panel Discussion – Prevention and Detection of4:00pm
         Diabetes After GDM: How Well are We Doing?
        Genetics3:00-5:30pm
        Leader: George Henry, MD
        Tabled 1
        I. Where should SMFM stand on 1st Trimester Screening?
         Mary D'Alton, MD
         Columbia Presbyterian Medical Center
         New York, NY
        II. Why 1st Trimester Screening is cost effective in the U.K
         Jon Hyett, MD
         Fetal Medicine Foundation
         London, UK
        III. Why 1st Trimester Screening of advanced maternal age patients is NOT cost effective in the U.S.
         George Henry, MD
         Reproductive Genetics Center
         Denver, CO
        IV. What is the scientific, social, cost effective, medicolegal, logical approach to 1st Trimester Screening?
         Mark Evans, MD
         Institute for Genetics & Fetal Medicine
         New York, NY
        Probable Panel
        Drs. Jack Larsen, Karen Filkens, Mary D'Alton, Jon Hyett, Simona Cicero
        Hypertension in Pregnancy3:00-6:00pm
        Leader: Chaur-Dong Hsu, MD, MPH
        Tabled 1
        I. Should Antepartum and Postpartum Corticosteroids Be Used in The Treatment of HELLP Syndrome?
         James Martin, MD
         University of Mississippi
         Jackson, MS
         Alex Fuks, MD and C.D. Hsu, MD
         New York Medical College
         Valhalla, NY
        Questions and Answers
        II. Bioactive and Immunoactive hCG in Preeclampsia/HELLP Syndrome
         A. Varaint Molecular Forms of HCG Possess Different Levels of Bioactivity
           Elliott Bedows, PhD
           University of Nebraska Medical Center
           Omaha, NE
         B. Bioactive and Immunoactive hCG in Preeclampsia/HELLP Syndrome
           Alex Fuks, MD and C.D. Hsu, MD
           New York Medical College
           Valhalla, NY
        Questions and Answers
        III. The Role of Fas in Preeclampsia
         A. Evidence for An Increased Sensitivity to Fas-mediated Apoptosis in Preeclampsia
          Donna Neale, MD
          Yale University
          New Haven, CT
         B. Soluble Fas and Fas Gene Polymorphism in Preeclampsia
          C.D. Hsu, MD
          New York Medical College
          Valhalla, NY
        Questions and Answers
        IV. North America Society for The Study of Hypertension in Pregnancy Business Meeting
         Thomas Easterling, MD (President)
        Infectious Disease3:00-5:10pm
        Leader: Alice R. Goepfert, MD
        Tabled 1
        I. Bedside Rapid PCR Testing for Group B Streptococcus3:00-3:45pm
         Ready for Prime Time?
         Mark Pearlman, MD
         Professor and Vice Chair
         Department of Ob/Gyn
         University of Michigan Health Systems
        II. Applications of Genomics and Proteomics to Infections and Inflammation3:45-4:30pm
         Michael G. Gravett, MD
         Professor, Obstetrics and Gynecology
         Chief, Maternal-Fetal Medicine
         Oregon Health Sciences University
        III. Pregnancy and HIV Transmission: The Effect on Maternal4:30-5:10pm
         Immune Cell Milieu and HIV-1 Co-Receptor Expression.
         Jeanne S. Sheffield, MD
         Assistant Professor
         Maternal-Fetal Medicine
         University of Texas, Southwestern Medical Center
        Maternal-Fetal Surgery3:00-6:00pm
        Leader: Joseph Bruner, MD
        FETAL THERAPY FROM HEAD TO TOE
        Tabled 1
        I. Models for Organization of Fetal Therapy3:00-3:15pm
         Mary D'Alton, MD
         Columbia Presbyterian Medical Center
         New York, NY
        II. HEAD
        Spina Bifida
        The MOMS Trial3:15-3:30pm
         Nancy Chescheir, MD
         University of North Carolina
         Chapel Hill, NC
        Valvular Stenosis3:30-3:35pm
         Louise Wilkens Haug, MD
         Brigham and Women's Hosptital
         Boston, MA
        III. LUNGS
        CDH
        The European Experience3:45-4:00pm
         Jan Deprest, MD
         Leuven, Belgium
        More US Trials4:00-4:15pm
         Michael Harrison, MD
         San Francisco, CA
        IV. ABDOMEN
        Gastroschisis
        Amnioexchange Trial4:15-4:30pm
         Joseph Bruner, MD
         Vanderbilt University Medical Center
         Nashville, TN
        LUTO
        Cystoscopy4:30-4:45pm
         R. Douglas Wilson, MD
         Children's Hospital of Philadelphia
         Philadelphia, Pa
        V. TWINS
        TTTS
        The NICHD Trial4:45-5:00pm
         Robert Ball, MD
         University of California, San Francisco
         San Francisco, CA
        The Tampa Trial5:00-5:15pm
         Ruben Quintero, MD
         Florida Perinatal Associates
         Tampa, FL
        TTTS- What's Left to Know?5:15-5:30pm
         William Cromblehome, MD
        Twin Discordance
        Laser Therapy for Twin Discordance5:30-5:45pm
         Ruben Quintero, MD
         Florida Perinatal Associates
         Tampa, FL
        VI. UTERUS
        PROM
        Amniopatch5:45-6:00pm
         Ruben Quintero, MD
         Florida Perinatal Associates
         Tampa, FL
        Perinatal Epidemiology 3:00-5:45pm
        Leader: David Stamillo, MD
        Topic: Methodological Controversies in Obstetric Clinical Research
        Course Description: The focus of this scientific forum will be two common areas of controversy in clinical research: stopping clinical trials and selecting meaningful & important primary outcomes. The Forum attendees will first review the operations of Data Monitoring & Safety Committees (DMSC), highlighting general topics of debate and conflict regarding committee conduct. Second, specific examples will be presented in which a clinical trial was stopped based on a controversial decision by a DMSC. Points and counterpoints regarding the decision to cease each trial will be outlined. Third, the benefits, limitations and pitfalls of using surrogate or composite primary outcomes in clinical research will be presented, incorporating examples from the obstetrical literature. Lectures will focus more on epidemiologic methods and clinical applications rather than biostatistical methods. Although the Forum will include short formal lectures, these are intended as a springboard for further non-structured discussion & debate.
        Tabled 1
        I. Data Monitoring and Safety Committees:3:00-3:45pm
         Operations & Conflicts
         Dwight J. Rouse, MD, MSPH
         Center for Research in Women's Health and Division of Maternal Fetal Medicine
         University of Alabama at Birmingham, Birmingham, AL
        II. Discussion and Questions3:45-4:00pm
        III. DMSC Controversies: When should a trial be stopped?4:00-4:45pm
         Elizabeth Thom, PhD
         George Washington University Biostatistics Center
         Washington, DC
        IV. Discussion and Questions4:45-5:00pm
        V. Surrogate or Composite Primary Outcomes: Benefits, Limitations & Controversies5:00-5:30pm
         Mark Klebanoff, MD, MPH
         Director, Division of Epidemiology, Statistics, and Prevention Research
         National Institute of Child Health and Human Development
         Bethesda, MD
        VI. Discussion and Questions5:30-5:45pm
        Preterm Labor3:00-5:30pm
        Leaders: Vincenzo Berghella, MD and Roberto Romero, MD
        Tabled 1
        I. Introduction to Program3:00-3:15pm
         Vincenzo Berghella, MD
        First part: March of Dimes White paper
        II. March of Dimes White Paper3:15-3:45pm
         Jay Iams, MD
        III. March of Dimes Panel Discussion3:45-4:00pm
        Moderators:
        Jay Iams, MD; Nancy Green, MD; Roberto Romero, MD; and Vincenzo Berghella, MD
        Second Part: Stress and Preterm Birth
        IV. The role of CRF and cortisol in preterm birth and review about the effects of stress on preterm birth4:00-4:40pm
         Pathik Wadhwa, MD
        V. The role of CRF-family in term and preterm labor4:40-5:10pm
         Pasquale Florio, MD
        VI. Summary of evidence and discussion5:10-5:30pm
         Cal Hobel, MD (Moderator)
        Ultrasound3:00-500pm
        Leader: Alfred Abuhamad, MD
        Tabled 1
        Title: 3D/4D In Fetal Echocardiography
        I. Technical Aspects of 3D Sonography in Fetal Echocardiography3:00-3:30pm
         Alfred Abuhamad, MD
         Eastern Virginia Medical School
         Norfolk, VA
        II. STIC and Color STIC In Fetal Echocardiography3:30-4:00pm
         Greggory De Vore, MD
         Pasadena, CA
        III. Automated Volume Sonography in Fetal Echocardiography4:00-4:30pm
         Alfred Abuhamad, MD
         Eastern Virginia Medical School
         Norfolk, VA
        IV. Mode Applications & Other Advance4:30-5:00pm
         Greggory De Vore, MD
         Pasadena, CA
        V. Questions and Answers5:00-5:15pm
         Drs. Abuhamad and De Vore
        Thursday, February 10
        International Society of Perinatal Obstetricians5:30-7:30pm
        Colm O’Herlihy, MD
        Scientific Sessions
        Friday, February 11
        International Society of Perinatal Obstetricians7:00-8:00am
        Business Meeting

        Special Focus Groups Thursday, February 10

        Women in Perinatology11:30am-1:00pm
        Leader: Jessica Bienstock, MD
        Box Lunch Meeting
        Speaker: Nancy Hueppchen, MD
        Johns Hopkins University School of Medicine
        Baltimore, MD
        Title: It's Your Epitaph…Loving Your Job and Your Life.
        As perinatologists we have chosen an inherently stressful lifestyle, but one with endless possibilities for enduring rewards. This interactive lunch will focus on how to achieve and maintain satisfaction by identifying your personal vision of success and how it can inspire you to love what you do.
        Research Support Personnel11:30am-1:00pm
        Leader: Karen Dorman
        Topic: TBA
        Box Lunch Meeting